1. Home
  2. NTRA vs TLN Comparison

NTRA vs TLN Comparison

Compare NTRA & TLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • TLN
  • Stock Information
  • Founded
  • NTRA 2003
  • TLN 2015
  • Country
  • NTRA United States
  • TLN United States
  • Employees
  • NTRA N/A
  • TLN N/A
  • Industry
  • NTRA Medical Specialities
  • TLN Electric Utilities: Central
  • Sector
  • NTRA Health Care
  • TLN Utilities
  • Exchange
  • NTRA Nasdaq
  • TLN Nasdaq
  • Market Cap
  • NTRA 21.7B
  • TLN 18.4B
  • IPO Year
  • NTRA 2015
  • TLN N/A
  • Fundamental
  • Price
  • NTRA $175.43
  • TLN $408.09
  • Analyst Decision
  • NTRA Strong Buy
  • TLN Strong Buy
  • Analyst Count
  • NTRA 16
  • TLN 13
  • Target Price
  • NTRA $193.50
  • TLN $349.23
  • AVG Volume (30 Days)
  • NTRA 914.8K
  • TLN 1.1M
  • Earning Date
  • NTRA 11-11-2025
  • TLN 11-13-2025
  • Dividend Yield
  • NTRA N/A
  • TLN N/A
  • EPS Growth
  • NTRA N/A
  • TLN N/A
  • EPS
  • NTRA N/A
  • TLN 3.80
  • Revenue
  • NTRA $1,964,250,000.00
  • TLN $2,128,000,000.00
  • Revenue This Year
  • NTRA $23.93
  • TLN $16.21
  • Revenue Next Year
  • NTRA $15.60
  • TLN $55.42
  • P/E Ratio
  • NTRA N/A
  • TLN $107.36
  • Revenue Growth
  • NTRA 44.38
  • TLN 1.09
  • 52 Week Low
  • NTRA $117.27
  • TLN $148.02
  • 52 Week High
  • NTRA $183.00
  • TLN $413.00
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 62.27
  • TLN 69.02
  • Support Level
  • NTRA $167.00
  • TLN $397.91
  • Resistance Level
  • NTRA $176.82
  • TLN $410.00
  • Average True Range (ATR)
  • NTRA 5.06
  • TLN 12.63
  • MACD
  • NTRA 0.13
  • TLN 1.12
  • Stochastic Oscillator
  • NTRA 86.08
  • TLN 90.17

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About TLN Talen Energy Corporation Common Stock

Talen Energy Corp is an independent power producer and energy infrastructure company. The company owns and operates approximately 10.7 gigawatts of power infrastructure in the United States. The group produces and sells electricity, capacity, and ancillary services into wholesale U.S. power markets, including PJM and WECC, with its generation fleet located in the Mid-Atlantic and Montana.

Share on Social Networks: